vs
Side-by-side financial comparison of Eos Energy Enterprises, Inc. (EOSE) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $58.0M, roughly 1.6× Eos Energy Enterprises, Inc.). Vericel Corp runs the higher net margin — 25.0% vs -207.7%, a 232.7% gap on every dollar of revenue. On growth, Eos Energy Enterprises, Inc. posted the faster year-over-year revenue change (699.6% vs 23.3%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $-75.2M).
Eos Energy Enterprises, Inc. is an energy storage solutions provider that designs, produces and deploys safe long-duration zinc-based battery systems. It serves utility, commercial, industrial and microgrid customers across North America, Europe and Asia, supporting grid stability and renewable energy integration.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
EOSE vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.0M | $92.9M |
| Net Profit | $-120.5M | $23.2M |
| Gross Margin | -93.8% | 78.7% |
| Operating Margin | -140.1% | 24.1% |
| Net Margin | -207.7% | 25.0% |
| Revenue YoY | 699.6% | 23.3% |
| Net Profit YoY | 55.1% | 17.3% |
| EPS (diluted) | $-0.53 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.0M | $92.9M | ||
| Q3 25 | $30.5M | $67.5M | ||
| Q2 25 | $15.2M | $63.2M | ||
| Q1 25 | $10.5M | $52.6M | ||
| Q4 24 | $7.3M | $75.4M | ||
| Q3 24 | — | $57.9M | ||
| Q2 24 | — | $52.7M | ||
| Q1 24 | — | $51.3M |
| Q4 25 | $-120.5M | $23.2M | ||
| Q3 25 | $-641.4M | $5.1M | ||
| Q2 25 | $-222.9M | $-553.0K | ||
| Q1 25 | $15.1M | $-11.2M | ||
| Q4 24 | $-268.1M | $19.8M | ||
| Q3 24 | — | $-901.0K | ||
| Q2 24 | — | $-4.7M | ||
| Q1 24 | — | $-3.9M |
| Q4 25 | -93.8% | 78.7% | ||
| Q3 25 | -111.2% | 73.5% | ||
| Q2 25 | -203.2% | 73.7% | ||
| Q1 25 | -234.7% | 69.0% | ||
| Q4 24 | -324.0% | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 68.9% |
| Q4 25 | -140.1% | 24.1% | ||
| Q3 25 | -200.6% | 5.1% | ||
| Q2 25 | -419.1% | -3.2% | ||
| Q1 25 | -506.2% | -24.3% | ||
| Q4 24 | -712.8% | 24.5% | ||
| Q3 24 | — | -4.3% | ||
| Q2 24 | — | -11.5% | ||
| Q1 24 | — | -10.7% |
| Q4 25 | -207.7% | 25.0% | ||
| Q3 25 | -2102.1% | 7.5% | ||
| Q2 25 | -1463.2% | -0.9% | ||
| Q1 25 | 144.7% | -21.4% | ||
| Q4 24 | -3696.7% | 26.3% | ||
| Q3 24 | — | -1.6% | ||
| Q2 24 | — | -8.9% | ||
| Q1 24 | — | -7.5% |
| Q4 25 | $-0.53 | $0.46 | ||
| Q3 25 | $-4.91 | $0.10 | ||
| Q2 25 | $-1.05 | $-0.01 | ||
| Q1 25 | $-0.20 | $-0.23 | ||
| Q4 24 | $-2.30 | $0.40 | ||
| Q3 24 | — | $-0.02 | ||
| Q2 24 | — | $-0.10 | ||
| Q1 24 | — | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $568.0M | $137.5M |
| Total DebtLower is stronger | $813.3M | — |
| Stockholders' EquityBook value | $-2.2B | $354.6M |
| Total Assets | $885.2M | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $568.0M | $137.5M | ||
| Q3 25 | $58.7M | $135.4M | ||
| Q2 25 | $120.2M | $116.9M | ||
| Q1 25 | $82.6M | $112.9M | ||
| Q4 24 | $74.3M | $116.2M | ||
| Q3 24 | — | $101.7M | ||
| Q2 24 | — | $102.5M | ||
| Q1 24 | — | $110.6M |
| Q4 25 | $813.3M | — | ||
| Q3 25 | $448.5M | — | ||
| Q2 25 | $445.3M | — | ||
| Q1 25 | $325.5M | — | ||
| Q4 24 | $316.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-2.2B | $354.6M | ||
| Q3 25 | $-2.3B | $321.9M | ||
| Q2 25 | $-1.1B | $306.8M | ||
| Q1 25 | $-942.2M | $295.5M | ||
| Q4 24 | $-1.1B | $292.0M | ||
| Q3 24 | — | $257.5M | ||
| Q2 24 | — | $243.0M | ||
| Q1 24 | — | $233.9M |
| Q4 25 | $885.2M | $488.0M | ||
| Q3 25 | $328.2M | $453.3M | ||
| Q2 25 | $361.0M | $435.6M | ||
| Q1 25 | $263.3M | $424.6M | ||
| Q4 24 | $260.3M | $432.7M | ||
| Q3 24 | — | $390.4M | ||
| Q2 24 | — | $376.8M | ||
| Q1 24 | — | $356.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-50.3M | $15.0M |
| Free Cash FlowOCF − Capex | $-75.2M | $12.8M |
| FCF MarginFCF / Revenue | -129.7% | 13.8% |
| Capex IntensityCapex / Revenue | 43.1% | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-265.0M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-50.3M | $15.0M | ||
| Q3 25 | $-65.9M | $22.1M | ||
| Q2 25 | $-66.1M | $8.2M | ||
| Q1 25 | $-28.9M | $6.6M | ||
| Q4 24 | $-42.7M | $22.2M | ||
| Q3 24 | — | $10.2M | ||
| Q2 24 | — | $18.5M | ||
| Q1 24 | — | $7.2M |
| Q4 25 | $-75.2M | $12.8M | ||
| Q3 25 | $-82.7M | $19.5M | ||
| Q2 25 | $-73.2M | $81.0K | ||
| Q1 25 | $-33.8M | $-7.6M | ||
| Q4 24 | $-55.8M | $8.5M | ||
| Q3 24 | — | $-9.2M | ||
| Q2 24 | — | $1.8M | ||
| Q1 24 | — | $-6.8M |
| Q4 25 | -129.7% | 13.8% | ||
| Q3 25 | -271.1% | 28.8% | ||
| Q2 25 | -480.2% | 0.1% | ||
| Q1 25 | -323.6% | -14.5% | ||
| Q4 24 | -769.1% | 11.2% | ||
| Q3 24 | — | -15.9% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | -13.3% |
| Q4 25 | 43.1% | 2.4% | ||
| Q3 25 | 55.2% | 3.9% | ||
| Q2 25 | 46.2% | 12.9% | ||
| Q1 25 | 47.0% | 27.0% | ||
| Q4 24 | 180.6% | 18.3% | ||
| Q3 24 | — | 33.5% | ||
| Q2 24 | — | 31.8% | ||
| Q1 24 | — | 27.3% |
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 4.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | -1.91× | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EOSE
Segment breakdown not available.
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
